Anti-ageing out? Longevity is the next frontier in beauty and wellness
Co-founded by renowned doctor Andrea Maier, Chi Longevity is one of two longevity clinics that have appeared in Singapore in recent months. PHOTO: CHI LONGEVITY
SINGAPORE – Once the domain of scientists and Silicon Valley biohackers, longevity has become mainstream and is rewriting the rules of beauty and wellness.
According to a report by London-based financial advisory firm Deloitte, the longevity sector – though still emerging – is drawing significant investment from venture capitalists, research institutions and governments.
Join ST's Telegram channel and get the latest breaking news delivered to you.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
10 hours ago
- Straits Times
Food poisoning throws Salernitana's relegation fight into turmoil
FILE PHOTO: Soccer Football - Serie A - Juventus v Salernitana - Allianz Stadium, Turin, Italy - May 12, 2024 Salernitana players celebrate after Niccolo Pierozzi scores their first goal REUTERS/Massimo Pinca/File Photo Salernitana's fight for survival has veered into chaos, with a bout of food poisoning hospitalising much of the squad halfway through their relegation showdown with Sampdoria. The Serie B side, fighting to avoid dropping to Italy's third tier, have formally requested a postponement of Friday's second-leg match against Sampdoria as players and coaching staff remain too ill to train. The drama unfolded on the plane back to Salerno following Sunday's 2-0 loss in Genoa, with 21 players and staff struck down, a large part requiring hospitalisation upon disembarking. "We are truly shocked by what happened and by the series of events that risk jeopardising Salernitana's smooth and peaceful approach to the final and crucial minutes of the season," club CEO Maurizio Milan said in a statement. The mass sickness has left the southern Italian side in competitive limbo, with the team unable to prepare for a match that could determine their footballing future. After suffering the drop from Serie A last season, Salernitana now face the prospect of consecutive relegations if they cannot overturn their first-leg deficit. "Many players and staff, at the moment, are not even able to show up at the sports centre to resume training," Milan added. The club said it had already made informal contact with Serie B officials and received "general openness" to evaluating their postponement request. Salernitana have also called for an investigation into the "causes of this widespread and serious episode." With the return leg scheduled for Friday and the team already facing a two-goal deficit, the clock is ticking on both the players' recovery and league authorities' decision on whether to grant additional time. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Business Times
a day ago
- Business Times
Livingstone Health's strategy rooted in patient care and steady growth
[SINGAPORE] Livingstone Health is not in a rush to grow. Much like the lithops – a hardy succulent also known as a living stone, from which the company takes its name – the Singapore-based healthcare group is taking a slow and steady approach to expansion. The Catalist-listed company, which went public in 2021, operates 20 clinics in the Republic, staffed by 22 medical specialists and practitioners. It also runs a health-screening centre, two medical aesthetics clinics, a podiatry clinic, and provides healthcare consultancy services within the region. 'We're at a stage where we don't want to grow for the sake of growing,' said chief commercial officer Dax Ng in an interview with The Business Times, alongside chief executive officer Wilson Tay. Both are executive directors on Livingstone's board. While rapid expansion is often seen as a way to get investors excited, Dr Tay believes the group's philosophy is better captured by its botanical namesake. 'No doubt, the growth, if you look at those succulents, can be a little bit slow,' he said. 'But given the correct conditions, they can flourish and flower.' A NEWSLETTER FOR YOU Friday, 2 pm Lifestyle Our picks of the latest dining, travel and leisure options to treat yourself. Sign Up Sign Up Indeed, Livingstone's pace of growth has been deliberate. After listing in 2021, it completed its first major acquisition just three years later. It acquired the remaining 49 per cent of Phoenix Medical Group (PMG) in 2024, after having first taken a 51 per cent stake in 2019. The acquisition of the healthcare provider, which has seven clinics across Singapore, has been both an 'accretive investment' and also a way for Livingstone to grow its primary healthcare segment through PMG's network. Livingstone's pace also reflects lessons from its early years as a listed company. Ng pointed to the importance of alignment and communication, especially when working with a relatively young team with an average age of around 40. 'A lot of times when you try to work in a team, people have thoughts and ideas that they try to keep to themselves,' he said. 'Over time, that's not healthy.' He added: 'When you go through experiences together with certain people, you realise there are a lot more things you can achieve. Once you have that trust and go through hardship together, you can have tougher conversations, which become easier because they're (more focused and constructive).' That trust enabled more open discussions on practical issues, including how to streamline operating expenses. The results showed up in its financial statement released on May 29: Livingstone swung back to profitability with a net profit of S$0.4 million for the second half-year ended Mar 31, reversing a net loss of S$2.9 million a year prior. Livingstone closed at S$0.023 on Friday (Jun 13), with a market capitalisation of around S$14.1 million. Recognition, relationships and rising needs Even without aggressive expansion, Livingstone caught the attention of RHB Singapore, which included it in the bank's Top 20 Small Cap Jewels 2025 report in May – the only healthcare group on the list. RHB's investment case for Livingstone was that it 'offers exposure to the ageing population and rising affluent trends in Singapore'. The bank also noted that Livingstone's performance is recovering, and anticipates its net profit to be on an uptrend moving forward. Ng called the recognition 'a good add to the group's profile' and noted that it came as a surprise. Dr Tay acknowledged that smaller healthcare companies such as Livingstone may be perceived as less capable than larger players. But he argued that in healthcare, value is not purely about scale. 'Of course, larger players may be able to manage some costs better – like lab tests or imaging,' he said. 'But it doesn't mean smaller healthcare groups can't deliver care that's meaningful. What matters most is the patient-doctor relationship.' That view is core to Livingstone's approach. Ng said the group's ethos is to ensure that patients who come through its general practitioner (GP) services are well taken care of – from seeing the right specialists, to recovery and follow-up if needed. To that end, it maintains a patient-care team that coordinates referrals between GPs and specialists, and works only with trusted external doctors vetted by its internal panel. Ng also pointed to the 'eminent concern' surrounding Singapore's ageing population – a demographic shift that Dr Tay said will accelerate over the next 10 to 20 years, and drive rising demand for healthcare services. To prepare for this, Livingstone has been using patient data to track rising incidences of chronic conditions such as diabetes. In response, the group added an endocrinologist – a specialist that treats diseases such as diabetes, as well as other hormonal and metabolic disorders – to its team in June. Dr Tay said Livingstone 'sees value' in having specialist disciplines that focus on managing chronic conditions, especially as the population ages, as it reflects on-the-ground needs. Looking outward In its latest financial update, Livingstone also outlined plans to diversify its revenue streams, including efforts to attract more international patients to its specialist healthcare segment through business development and marketing initiatives. When asked if this meant a push into medical tourism, Ng demurred, and suggested that the sector may be 'dying' in Singapore due to cost pressures and competition abroad. While the team recognises that Livingstone has limited control over the broader healthcare landscape, Ng believes the group can compete on quality. 'We can attract the right medical talent, and groom them with the right patient ethos and care standards,' he said. 'From there, we can build a brand to attract good international patients who are still willing to pay the extra dollar for quality.' On the future of healthcare, Dr Tay noted that even as the sector increasingly looks to technology for efficiency, the human element remains irreplaceable. 'We treat the patients, not just the disease,' he said. 'We treat their emotions and we (seek) to understand them…Things that a computer cannot do.' 'Medicine is always a science, but, more so, it is an art.'
Straits Times
a day ago
- Straits Times
Forum: All medical procedures, including injectable treatments, carry risks
We refer to the article 'More younger Singaporeans are getting Botox and collagen shots. How effective and safe are they?' (June 9 ). In the field of aesthetic medicine, there is a broad spectrum of treatment modalities available. While procedures such as Botox and injectables are increasingly popular and effective, relying solely on them may limit optimal outcomes. In patients whose aesthetic goals cannot be realistically achieved with injectables alone, excessive or repeated use may not only lead to suboptimal outcomes, but also increase the risk of complications. Recognising when alternative or adjunctive surgical treatment modalities are more appropriate is essential to ensure both treatment efficacy and patient safety. A balanced approach that considers both non-invasive and surgical options, when appropriate, is key to achieving safe, comprehensive and lasting results. A common misconception is that injectable treatments are inherently safe simply because they are less invasive and offer temporary results. Although they are generally safe when performed by trained professionals, all medical procedures carry risks. In rare but severe cases, complications such as blindness have been reported locally. Additionally, some temporary injectable products may lead to delayed complications such as granulomas, or firm nodules under the skin, which can require medical or surgical management. We advocate a holistic and balanced approach to aesthetic care, which emphasises long-term, natural outcomes and places the individual needs and safety of each patient at the core of all treatment decisions. Assoc Prof Ong Yee Siang President Singapore Association of Plastic Surgeons Dr Jonah Kua Ee Hsiang President Singapore Society of Cosmetic (Aesthetic) Surgeons Clin Asst Prof Jeremy Sun Mingfa Chairman Chapter of Plastic Reconstructive and Aesthetic Surgeons, College of Surgeons, Singapore More on this Topic Forum: What readers are saying Join ST's Telegram channel and get the latest breaking news delivered to you.
